LINC00115 promotes gastric cancer partly by the miR-212-5p/ATPAF1 axis

ZHU, QINGXI; TAN, JIE; ZHAN, TING; LIU, MENG; ZOU, YANLI; LIU, WEIJIE

doi:10.1590/0001-3765202320230480

home Sumário navigate_before Anterior Atual Seguinte navigate_next

Texto (Inglês)

Download PDF (Inglês)

Texto (Inglês)
Download PDF (Inglês)

Whatsapp
BlueSky
Mastodon
Facebook
Mais

home Sumário

Facebook
X
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley

Texto (Inglês)

Download PDF (Inglês)

HEALTH SCIENCES • An. Acad. Bras. Ciênc. 95 (suppl 2) • 2023 • https://doi.org/10.1590/0001-3765202320230480 linkcopy

LINC00115 promotes gastric cancer partly by the miR-212-5p/ATPAF1 axis

Authorship SCIMAGO INSTITUTIONS RANKINGS

Abstract

LncRNAs are known to be key regulators in the initiation and development of diverse cancers. Whether LINC00115 is involved in the regulation of gastric cancer (GC) progression remains unclear. Here, we aimed to show the function of LINC00115 in GC. RT-qPCR was used to measure gene expression in GC tissues and cells. Colony formation, EdU, TUNEL, and wound healing assays were used to analyze cellular processes in GC. The in vivo GC xenograft model was established. We observed that LINC00115 was highly expressed in GC. Functionally, silencing LINC00115 inhibited GC cell proliferation, and migration but facilitated GC apoptosis. Mechanistically, LINC00115 sponged miR-212-5p, while miR-212-5p targeted ATPAF1 in GC cells. Rescue assays showed ATPAF1 overexpression countervailed the inhibitory role of LINC00115 depletion in GC progression in vitro and in vivo. Overall, LINC00115 promoted GC progression by upregulating ATPAF1 via miR-212-5p.

Key words
LINC00115; gastric cancer; miR-212-5p; ATPAF1

Authorship

person QINGXI ZHU

conceived and designed the experiments · carried out the experiments · analyzed the data · drafted the manuscript

schoolTongren Hospital of Wuhan University (Wuhan Third Hospital), Department of Gastroenterology, No.241, Pengliuyang Road, Wuhan 430060, Hubei, ChinaTongren Hospital of Wuhan University (Wuhan Third Hospital)ChinaWuhan, Hubei, ChinaTongren Hospital of Wuhan University (Wuhan Third Hospital), Department of Gastroenterology, No.241, Pengliuyang Road, Wuhan 430060, Hubei, China

0000-0001-7154-9939

person JIE TAN

conceived and designed the experiments · carried out the experiments · analyzed the data · drafted the manuscript

0000-0002-8861-1134

person TING ZHAN

carried out the experiments

0000-0003-0622-7890

person MENG LIU

carried out the experiments

0000-0002-3332-1316

person YANLI ZOU

carried out the experiments · analyzed the data · drafted the manuscript

0000-0001-8818-9001

person WEIJIE LIU

carried out the experiments · analyzed the data · drafted the manuscript

0000-0002-5763-7286

Correspondence to: Yanli Zou, Weijie Liu E-mail: haisizou@163.com, 172077205@qq.com *These authors contributed equally to the work.

SCIMAGO INSTITUTIONS RANKINGS

Tongren Hospital of Wuhan University (Wuhan Third Hospital), Department of Gastroenterology, No.241, Pengliuyang Road, Wuhan 430060, Hubei, ChinaTongren Hospital of Wuhan University (Wuhan Third Hospital)ChinaWuhan, Hubei, ChinaTongren Hospital of Wuhan University (Wuhan Third Hospital), Department of Gastroenterology, No.241, Pengliuyang Road, Wuhan 430060, Hubei, China

Figures

Figures (5)

Thumbnail

Figure 1 LINC00115 knockdown suppressed GC cell growth. (a) The LINC00115 level in GC tissues and nontumor issues was detected by RT-qPCR. (b) RT-qPCR was used to evaluate the LINC00115 level in GC cells. (c) The knockdown efficiency of LINC00115 was measured by RT-qPCR in HGC-27 and AGS cells. (d) Colony formation and (e) EdU assays were performed to assess cell proliferation after transfection of sh-NC or sh-LINC00115. (f) Cell apoptosis of HGC-27 and AGS in the two groups was detected by TUNEL assay. (g) Wound healing assay was performed to assess the migratory capability of HGC-27 and AGS cells after transfection. (h) The protein levels of matrix metalloproteinases (MMP2 and MMP9) in sh-LINC00115 and sh-NC groups were detected by western blot. **p<0.01, ***p<0.001.

Thumbnail

Figure 2 LINC00115 sponged miR-212-5p in GC cells. (a) Subcellular fractionation assay was applied to determine the location of LINC00115 in HGC-27 and AGS cells. (b) Three miRNAs sharing binding sites with LINC00115 were found; pulldown assay was conducted to select the most suitable miRNA for LINC00115. (c) and (d) The miR-212-5p level in GC tissues and cells was measured by RT-qPCR. (e) Binding site of miR-212-5p on LINC00115. (f) Overexpression efficiency of miR-212-p in GC cells. (g) Luciferase reporter assay was conducted to test the binding of LINC00115 to miR-212-5p. (h) The expression correlation between LINC00115 and miR-212-5p in GC tissues by Pearson correlation analysis. **p<0.01, ***p<0.001.

Thumbnail

Figure 3 ATPAF1 was targeted by miR-212-5p. (a) The expression levels of potential target mRNAs in GC cells transfected with miR-212-5p mimics were detected by RT-qPCR. (b) The protein level of ATPAF1 after miR-212-5p upregulation was detected by western blot. (c) Binding site of miR-212-5p on ATPAF1. (d) The binding between ATPAF1 and miR-212-5p was determined by luciferase reporter assay. (e) Downregulation efficiency of miR-212-5p was tested by RT-qPCR. (f) The effect of LINC00115 silencing together miR-212-5p downregulation on ATPAF1 mRNA expression and protein level. (g) and (h) The ATPAF1 level in GC tissues and cells. (i) The relationship between ATPAF1 expression and the overall survival of GC patients was predicted with online tool (https://kmplot.com). **p<0.01, ***p<0.001.

Thumbnail

Figure 4 LINC00115 knockdown restrained GC cellular processes through the regulation of ATPAF1. (a) The transfection efficiency of ATPAF1 overexpression in HGC-27 cells. HGC-27 cell proliferation after transfection with sh-NC, sh-LINC00115, or sh-LINC00115+ATPAF1 was detected by (b) colony formation and (c) EdU assays. (d) The apoptosis of HGC-27 cells in the groups of sh-NC, sh-LINC00115, or sh-LINC00115+ATPAF1 was assessed with TUNEL assay. (e) Wound healing assay was adopted to evaluate the migration of HGC-27 cells in the three groups. (f) Western blot analysis detected the protein levels of matrix metalloproteinases (MMP2 and MMP9) in HGC-27 cells transfected with the indicated plasmids. ***p<0.001.

Thumbnail

Figure 5 LINC00115 silencing suppressed tumorigenesis in vivo by downregulating ATPAF1. (a) Representative images of the xenograft tumors in subcutaneous xenograft mouse model injected with HGC-27 cells transfected with sh-NC, sh-LINC00115 and sh-LINC00115+ATPAF1. (b) and (c) Tumor volume and weight of the xenograft in each group. ***p<0.001.

imageFigure 1 LINC00115 knockdown suppressed GC cell growth. (a) The LINC00115 level in GC tissues and nontumor issues was detected by RT-qPCR. (b) RT-qPCR was used to evaluate the LINC00115 level in GC cells. (c) The knockdown efficiency of LINC00115 was measured by RT-qPCR in HGC-27 and AGS cells. (d) Colony formation and (e) EdU assays were performed to assess cell proliferation after transfection of sh-NC or sh-LINC00115. (f) Cell apoptosis of HGC-27 and AGS in the two groups was detected by TUNEL assay. (g) Wound healing assay was performed to assess the migratory capability of HGC-27 and AGS cells after transfection. (h) The protein levels of matrix metalloproteinases (MMP2 and MMP9) in sh-LINC00115 and sh-NC groups were detected by western blot. p<0.01, *p<0.001. open_in_new

imageFigure 2 LINC00115 sponged miR-212-5p in GC cells. (a) Subcellular fractionation assay was applied to determine the location of LINC00115 in HGC-27 and AGS cells. (b) Three miRNAs sharing binding sites with LINC00115 were found; pulldown assay was conducted to select the most suitable miRNA for LINC00115. (c) and (d) The miR-212-5p level in GC tissues and cells was measured by RT-qPCR. (e) Binding site of miR-212-5p on LINC00115. (f) Overexpression efficiency of miR-212-p in GC cells. (g) Luciferase reporter assay was conducted to test the binding of LINC00115 to miR-212-5p. (h) The expression correlation between LINC00115 and miR-212-5p in GC tissues by Pearson correlation analysis. p<0.01, *p<0.001. open_in_new

imageFigure 3 ATPAF1 was targeted by miR-212-5p. (a) The expression levels of potential target mRNAs in GC cells transfected with miR-212-5p mimics were detected by RT-qPCR. (b) The protein level of ATPAF1 after miR-212-5p upregulation was detected by western blot. (c) Binding site of miR-212-5p on ATPAF1. (d) The binding between ATPAF1 and miR-212-5p was determined by luciferase reporter assay. (e) Downregulation efficiency of miR-212-5p was tested by RT-qPCR. (f) The effect of LINC00115 silencing together miR-212-5p downregulation on ATPAF1 mRNA expression and protein level. (g) and (h) The ATPAF1 level in GC tissues and cells. (i) The relationship between ATPAF1 expression and the overall survival of GC patients was predicted with online tool (https://kmplot.com). p<0.01, *p<0.001. open_in_new

imageFigure 4 LINC00115 knockdown restrained GC cellular processes through the regulation of ATPAF1. (a) The transfection efficiency of ATPAF1 overexpression in HGC-27 cells. HGC-27 cell proliferation after transfection with sh-NC, sh-LINC00115, or sh-LINC00115+ATPAF1 was detected by (b) colony formation and (c) EdU assays. (d) The apoptosis of HGC-27 cells in the groups of sh-NC, sh-LINC00115, or sh-LINC00115+ATPAF1 was assessed with TUNEL assay. (e) Wound healing assay was adopted to evaluate the migration of HGC-27 cells in the three groups. (f) Western blot analysis detected the protein levels of matrix metalloproteinases (MMP2 and MMP9) in HGC-27 cells transfected with the indicated plasmids. ***p<0.001. open_in_new

imageFigure 5 LINC00115 silencing suppressed tumorigenesis in vivo by downregulating ATPAF1. (a) Representative images of the xenograft tumors in subcutaneous xenograft mouse model injected with HGC-27 cells transfected with sh-NC, sh-LINC00115 and sh-LINC00115+ATPAF1. (b) and (c) Tumor volume and weight of the xenograft in each group. ***p<0.001. open_in_new

How to cite

linkcopy

vertical_align_top show_chart

more_horiz close
- image
- translate
- link
- article
- vertical_align_top
- file_download
- show_chart
- image
- translate
- link
- article

location_on

Academia Brasileira de Ciências Rua Anfilófio de Carvalho, 29, 3º andar, 20030-060 Rio de Janeiro RJ Brasil, Tel: +55 21 3907-8100 - Rio de Janeiro - RJ - Brazil
E-mail: aabc@abc.org.br

rss_feed Acompanhe os números deste periódico no seu leitor de RSS

Versão para download de PDF

PDF

Inglês

Versões e tradução automática

Versão original do texto

English

Tradução automática

Google Translator
Microsoft Translator

Como citar

RIS

BIBTEX

Outros formatos de citação e exportação: